David Broecker

David is currently serving as board executive and acting CEO to Apexian Pharmaecuticals. He has served on the board of directors since 2013 and was interim CEO in 2014 to 2015. David is an experienced business executive with a passion and track record for building organizations and creating value by advancing breakthrough innovation to the marketplace. He currently serves as the Chief Innovation and Collaboration Officer for Purdue Research Foundation. In this role, David is responsible for advancing strategic innovation initiatives targeting corporate partners and key stakeholders.

David is the Founder and CEO of Zorion Medical, a leading medical device company focused on developing and commercializing fully absorbable technology utilizing bio-metals. The first set of applications target peripheral artery disease including arterial dissections, congenital vascular defects in children, and AV fistulas in renal-dialysis patients.

Prior to joining Purdue, David was the Founding President and CEO of the Indiana Biosciences Research Institute in Indianapolis, IN – an independent, non-profit research organization dedicated to discovery science and applied research initially targeting diabetes, cardiometabolic disease, and poor nutrition, inspired by the state’s leading life sciences companies.

David was President and CEO of Alkermes, a publicly traded biotechnology company, leading the organization through significant transformation with the launch of several new products, including Vivitrol – the only long acting treatment for alcohol and opiate dependence. As both an intra- and entrepreneur, he has led teams in a range of organizations, including multiple start-ups. David started his career at Eli Lilly and Company and for more than 15 years was responsible for supporting the development and commercialization of multiple pharmaceutical, medical device, and diagnostic products.

David received his undergraduate degree from Wabash College where he was a chemistry and mathematics major, graduating summa cum laude and as a member of Phi Beta Kappa. He completed a graduate degree in chemical engineering from the Massachusetts Institute of Technology and his M.B.A. from the University of Chicago. He currently serves on the boards of Zorion Medical, Inc., Apexian Pharmaceuticals, and InScope Medical. David is a trustee at Wabash College, chairing the committee on Trusteeship.

David received his undergraduate degree from Wabash College where he was a chemistry and mathematics major, graduating summa cum laude and as a member of Phi Beta Kappa. He completed a graduate degree in chemical engineering from the Massachusetts Institute of Technology and his M.B.A. from the University of Chicago. He currently serves on the boards of Apexian Pharmaceuticals, Zorion Medical, Inc., and InScope Medical. David is a trustee at Wabash College, chairing the committee on Trusteeship.